There is clinical data for Kawasaki disease, childhood ITP and SLE that correlated disease outcomes as well as response to treatment are associated with FCGR2/3 variants as well as copy number variation of CNR1 (Table 3). This evidence concerns the gene FCGR2B and systemic lupus erythematosus.